Chorionic gonadotropin Puretrig Injection IP (Gufic Ltd.) 5000 ME

Gonadotropin chorionic injection Puretrig 5000 ME is a sports drug belonging to the group of peptide hormones. This drug, although not approved in sports pharmacology due to its doping status, is used in women during pregnancy, stimulating the production of progesterone and estradiol, and also in men, increasing the efficiency of testosterone synthesis.

The drug is presented in the form of a dry porous substance for intramuscular administration. Its composition includes chorionic gonadotropin as an active substance and mannitol as an auxiliary substance. This drug is in demand due to its affordable cost, which facilitates its regular use.

Course of reception and dosage of chorionic gonadotropin The dosage of the drug should be selected by the doctor individually, taking into account the characteristics of the body. A cycle of less than a week and in minimal dosages does not require the use of Chorionic Gonadotropin 5000 IU. With higher doses and long-term use, two injections per week (300-500 IU) are prescribed. Injections are given every other day for 3 weeks. Ls The highest concentration of the drug is observed 5-12 hours after administration, it is excreted for 30 hours through the kidneys.

Pharmacological action of chorionic gonadotropin is to stimulate the development of genital organs and secondary sexual characteristics. In men, it promotes increased production of testosterone and stimulates spermatogenesis, while in women it causes ovulation and the synthesis of progesterone and estrogens.

Side effects from reception and overdose of Chorionic Gonadotropin Puretrig

These side effects and violations of this nature are noted:

• from the side of the immune system;

• at the place of drug administration;

• metabolism;

• psyche;

• nervous system;

• endocrine system;

• leather;

• genital organs.

Sometimes a rash or fever occurs. It is important to monitor reactions at injection sites (painful sensations, bruises, irritations). Edema, mood changes - irritability, increased anxiety are noted in women. Fatigue, dizziness, headaches are possible.

Contraindications

Increased sensitivity to individual components and allergic reactions prohibit the use of the product. Chorionic Gonadotrop. Puretrig is contraindicated for damage to the central nervous system, thrombophlebitis, hypothyroidism, primary ovarian failure, pregnancy and breastfeeding. It should be used with caution in persons at risk of developing thrombosis, severe obesity, and heart failure. It is not recommended for boys in the prepubertal period.